Previously, we showed that the therapeutic effects of probiotic Lactobacillus rhamnoses GG (LGG) in mouse models of fatty liver diseases are mediated by FGF21/adiponectin upregulation [29,30]. The gene discussed is FGF21; the disease is fatty liver disease.